An exploratory study of NS-580 in patients with endometriosis (early phase II)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223592

Enrollment

150

Registered

2017-07-18

Start date

2017-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

investigational material(s) Generic name etc : NS-580 INN of investigational material : - Therapeutic category code : 259 Other agents for uro-genital and anal organ Dosage and Administration for Inve

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who have been clinically diagnosed with endometriosis

Exclusion criteria

Exclusion criteria: Patients for whom surgical treatment for an organic disease is judged by the principal (sub-) investigator to be a priority Patients with ovarian endometriomas that are found to be containing solid components Patients who may be taking analgesics regularly during the study period

Design outcomes

Primary

Measure	Time frame
efficacy exploratory The change in pain VAS score	—

Secondary

Measure	Time frame
efficacy exploratory The change in EHP-30 score	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026